12
Participants
Start Date
July 3, 2016
Primary Completion Date
December 16, 2017
Study Completion Date
May 29, 2018
MDMA
Two sessions of MDMA-assisted therapy, one with an initial dose of 75 mg midomafetamine HCl (and optional supplemental dose of 37.5 mg) and the second with 75 or 100 mg midomafetamine HCl (with optional supplemental dose of either 37.5 mg or 50 mg respectively) given to the participant with PTSD and their significant other.
CBCT
A three-phase, 15-session, manualized treatment from the CBCT manual
Therapy
Manualized MDMA-assisted therapy
Offices of Michael Mithoefer MD, Mt. Pleasant
Lead Sponsor
Lykos Therapeutics
INDUSTRY